Cassava's stock tumbles again, after Quanterix said it 'did not'

Cassava's stock tumbles again, after Quanterix said it 'did not' prepare data charts presented by Cassava, that are under dispute

Published: Aug. 27, 2021 at 8:58 a.m. ET

By 

Tomi Kilgore

0

 

 

• Email icon
• Facebook icon
• Twitter icon
• Linkedin icon
• Flipboard icon

• Print icon
• Resize icon

Referenced Symbols

• QTRX
  -9.21% 
  SAVA
  -12.38% 

 

 

Quanterix Corp. QTRX, -9.21% said that while it was previously engaged by Cassava Sciences Inc. SAVA, -12.38% to perform sample testing, the digitized biomarker analysis company said it, or its employees, "did not interpret the test results or prepare the data charts" presented by Cassava to the Alzheimer's Association International Conference (AAIC) in July, or otherwise. Earlier this week, in Cassava's response to a request the Food and Drug Administration halt clinical studies of Cassava's Alzheimer's treatment because of concerns over the accuracy and integrity of presented biomarker data, Cassava had said that data from Alzheimer's patients were generated by Quanterix. The news of the halt request had sent Cassava's stock plunging 39.9% in two days through Thursday. Quanterix's stock dropped 9.2% on Thursday, after losing 1.5% on Wednesday. In Friday's statement, Quanterix said it is "widely recognized for its commitment to business integrity and to upholding the highest standards of quality." Quanterix's stock rose 4.5% in premarket trading, while Cassava shares tumbled 21.2%

所有跟帖： 

• 看样子sava极可能真的造假 -huntridge- ♂ (0 bytes) () 08/27/2021 postreply 06:32:30

• 找出来争议的data, 今年7月会议的poster。还真有问题 -三丝- ♂ (249698 bytes) () 08/27/2021 postreply 07:18:08

• 首先，64个病人的数据只有51人总结在下面图中 -三丝- ♂ (152230 bytes) () 08/27/2021 postreply 07:21:35

• 这是petition中的举证，235%虽然不太精确，但看不到图4相应的数据点 -三丝- ♂ (517974 bytes) () 08/27/2021 postreply 07:32:07